154 related articles for article (PubMed ID: 21572733)
1. Change in quality of life after medical and surgical treatment of graves' ophthalmopathy.
Kashkouli MB; Heidari I; Pakdel F; Jam S; Honarbakhsh Y; Mirarmandehi B
Middle East Afr J Ophthalmol; 2011 Jan; 18(1):42-7. PubMed ID: 21572733
[TBL] [Abstract][Full Text] [Related]
2. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments.
Terwee CB; Dekker FW; Mourits MP; Gerding MN; Baldeschi L; Kalmann R; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Mar; 54(3):391-8. PubMed ID: 11298093
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of quality of life in patients with Graves´ ophthalmopathy, before and after orbital decompression.
Iacobæus L; Sahlin S
Orbit; 2016 Jun; 35(3):121-5. PubMed ID: 27159575
[TBL] [Abstract][Full Text] [Related]
4. The Psychosocial and Clinical Outcomes of Orbital Decompression Surgery for Thyroid Eye Disease and Predictors of Change in Quality of Life.
Wickwar S; McBain H; Ezra DG; Hirani SP; Rose GE; Newman SP
Ophthalmology; 2015 Dec; 122(12):2568-76.e1. PubMed ID: 26421706
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Ophthalmic Surgery for Graves' Orbitopathy on Quality of Life: A Systematic Review and Meta-Analysis.
Woo T; Li C; Ganesananthan S; Rajendram R; Uddin J; Lee RWJ; Dayan C; Taylor P
Thyroid; 2022 Feb; 32(2):177-187. PubMed ID: 34877883
[No Abstract] [Full Text] [Related]
6. How Effective is Superolateral Orbital Decompression in Cases of Drug-Resistant Graves' Ophthalmopathy.
Shamov T; Eftimov T; Krasimirov G
Folia Med (Plovdiv); 2020 Sep; 62(3):462-467. PubMed ID: 33009740
[TBL] [Abstract][Full Text] [Related]
7. Development and psychometric properties of the Thai Graves' ophthalmopathy quality of life (GO-QOL) questionnaire.
Lumyongsatien M; Keeratidamkerngsakul B; Pornpanich K; Vangveeravong S; Saonanon P; Wiwatwongwana D; Mahaisavariya P; Aryasit O; Pongpirul K
J Patient Rep Outcomes; 2019 Dec; 4(1):1. PubMed ID: 31893319
[TBL] [Abstract][Full Text] [Related]
8. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
Wickwar S; McBain HB; Ezra DG; Hirani SP; Rose GE; Newman SP
Eye (Lond); 2015 Jul; 29(7):951-7. PubMed ID: 25998940
[TBL] [Abstract][Full Text] [Related]
9. Assessing quality of life in Australian patients with Graves' ophthalmopathy.
Park JJ; Sullivan TJ; Mortimer RH; Wagenaar M; Perry-Keene DA
Br J Ophthalmol; 2004 Jan; 88(1):75-8. PubMed ID: 14693779
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation by quality of life questionnaires in patients undergoing strabismus surgery in Graves' disease].
Schaut A; Cloché V; Mouna A; Angioi K; Berrod JP; Conart JB; Maalouf T
J Fr Ophtalmol; 2018 Nov; 41(9):814-822. PubMed ID: 30217613
[TBL] [Abstract][Full Text] [Related]
11. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy.
Kulig G; Andrysiak-Mamos E; Sowińska-Przepiera E; Kulig J; Karakiewicz B; Brodowski J; Robaczyk M; Homa K; Letkiewicz M; Syrenicz A
Endokrynol Pol; 2009; 60(3):158-65. PubMed ID: 19569015
[TBL] [Abstract][Full Text] [Related]
12. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves' disease.
Delfino LC; Zunino A; Sapia V; Croome MDCS; Ilera V; Gauna AT
Arch Endocrinol Metab; 2017; 61(4):374-381. PubMed ID: 28225858
[TBL] [Abstract][Full Text] [Related]
13. Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
Kahaly GJ; Douglas RS; Holt RJ; Sile S; Smith TJ
Lancet Diabetes Endocrinol; 2021 Jun; 9(6):360-372. PubMed ID: 33865501
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of endoscopic orbital decompression for graves' ophthalmopathy.
Woods RSR; Pilson Q; Kharytaniuk N; Cassidy L; Khan R; Timon CVI
Ir J Med Sci; 2020 Feb; 189(1):177-183. PubMed ID: 31203506
[TBL] [Abstract][Full Text] [Related]
15. Effects of Graves' ophthalmopathy on quality of life.
Wiersinga WM; Prummel MF; Terwee CB
J Endocrinol Invest; 2004 Mar; 27(3):259-64. PubMed ID: 15165002
[TBL] [Abstract][Full Text] [Related]
16. Assessing Graves' ophthalmopathy-specific quality of life in Korean patients.
Choi YJ; Lim HT; Lee SJ; Lee SY; Yoon JS
Eye (Lond); 2012 Apr; 26(4):544-51. PubMed ID: 22241019
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Impact of Ambulatory Care Based on Social Support on the Quality of Life of Patients with Graves' Ophthalmopathy.
Sun R; Li J; Li Y; Liu W; Xing L; Zhang J
Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38843425
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
19. [Endoscopic trans-ethmoid medial orbital wall decompression combined with intraconal fat decompression for Graves' ophthalmopathy].
Wu WC; Yu B; Wang ML; Huang L; Tu YH; Chen B; Qu J; Wang QM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):807-13. PubMed ID: 22321417
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients.
Villagelin D; Romaldini J; Andrade J; Santos R; Milkos A; Teixeira PFDS; Ward LS
Front Endocrinol (Lausanne); 2019; 10():192. PubMed ID: 31024443
[No Abstract] [Full Text] [Related]
[Next] [New Search]
